Leprosy can be detected early: study

Image
Press Trust of India London
Last Updated : Jun 09 2015 | 5:07 PM IST
Leprosy patients, including thousands in India where the disease is most prevalent, can now live better lives as the chronic infectious ailment can be detected long before it manifests as skin lesions, researchers said today.
Peripheral nerve damage is the hallmark of leprosy pathology, but its origins had remained unclear until now.
Experts have been exploring the relationship between Mycobacterium leprae, a bacteria which causes leprosy, and the formation of the membrane attack complex (MAC), which is a tool deployed by the innate immune system to fight pathogens.
According to new research, inhibition of MAC formation - which can damage adjacent health tissues and trigger inflammation at the early stages of the disease - reduces nerve damage and improves regeneration and functional recovery.
"Our new research shows that inflammatory reactions can be prevented at an early stage of the disease, reducing the risk of the nerve damage that leads to the disabilities caused by leprosy. We propose that MAC inhibition could form the basis of the future development of novel therapeutics from leprosy," said Professor Pranab K Das, Senior Research Fellow at University of Birmingham.
Despite a marked decline in the number of cases of leprosy since the 1980s and effective multidrug therapy (MDT), the disease remains endemic in several countries, including India - where the disease is most prevalent.
Almost 135,000 new cases of the disease were reported in India during 2012.
The fall in new case detection doesn't mean that the disease is becoming less of a public health problem globally, Das, a Senior Research Fellow, warned.
"Our research has shown that fewer people have been diagnosed with leprosy in Brazil due to the decline in clinical knowledge about the disease, and we believe this may also be the case in India," Das said.
"Coupled with leprosy's long incubation period, there also remains the stigma attached to those who have leprosy, which prevents many coming forward for treatment at the earliest stage," he added.
The research was conducted in Brazil along with academics from University of Amsterdam, Netherlands and University of Birmingham.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 09 2015 | 5:07 PM IST

Next Story